PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing

Journal of Drug Targeting

Volumn 11, Issue 2, 2003, Pages 87-92

  Gao, Z ^a   Lukyanov, A N ^a   Chakilam, A R ^a   Torchilin, V P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Anticancer antibody; Cytotoxicity; Immunomicelles; Taxol (paclictaxel); Tumor cell targeting

Indexed keywords

MACROGOL 20000; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2C5; PACLITAXEL; PHOSPHATIDYLCHOLINE; PHOSPHOETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EGG; MICELLE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MICE; MICELLES; NUCLEOSOMES; PACLITAXEL; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; TUMOR CELLS, CULTURED;

EID: 0038268753     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186031000138623     Document Type: Article

References (23)

1. Alkan-Onyuksel, H., Ramakrishnan, S., Chai, H.B. and Pezzuto, J.M. (1994) "A mixed micellar formulation suitable for the parenteral administration of taxol", Pharm. Res. 11, 206-212.
2. Balasubramanian, S.V. and Straubinger, R.M. (1994) "Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes", Biochemistry 33, 8941-8947.
3. Dosio, F., Arpicco, S., Brusa, P., Stella, B. and Cattel, L. (2001) "Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics", J. Control. Release 76, 107-117.
4. Foa, R., Norton, L. and Seidman, A.D. (1994) "Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity", Int. J. Clin. Lab. Res. 24, 6-14.
5. Gao, Z., Lukyanov, A.N., Singhal, A. and Torchilin, V.P. (2002) "Diacylpolymer micelles as nanocarriers for poorly soluble anticancer drugs", Nano Lett. 2, 979-982.
6. Horwitz, S.B. (1992) "Mechanism of action of taxol", Trends Pharmacol. Sci. 13, 134-136.
7. Iakoubov, L.Z. and Torchilin, V.P. (1997) "A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice", Oncol. Res. 9, 439-446.
8. Iakoubov, L., Rokhlin, O. and Torchilin, V. (1995) "Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells", Immunol. Lett. 47, 147-149.
9. Lukyanov, A.N., Gao, Z., Mazzola, L. and Torchilin, V.P. (2002) "Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice", Pharm. Res. 19, 1424-1429.
10. Lundberg, B.B. (1997) "A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol)", J. Pharm. Pharmacol. 49,16-21.
11. Parr, M.J., Masin, D., Cullis, P.R. and Bally, M.B. (1997) "Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol)", J. Pharmacol. Exp. Ther. 280, 1319-1327.
12. Ramaswamy, M., Zhang, X., Burt, H.M. and Wasan, K.M. (1997) "Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers", J. Pharm. Sci. 86, 460-464.
13. Rowinsky, E.K. and Donehower, R.C. (1993) "The clinical pharmacology of paclitaxel (Taxol)", Semin. Oncol. 20(4 Suppl. 3), 16-25.
14. Rowinsky, E.K., Eisenhauer, E.A., Chaudhry, V., Arbuck, S.G. and Donehower, R.C. (1993) "Clinical toxicities encountered with paclitaxel (Taxol)", Semin. Oncol. 20(4 Suppl. 3), 1-15.
15. Sarosy, G. and Reed, E. (1993) "Taxol dose intensification and its clinical implications", J. Natl Med. Assoc. 85, 427-431.
16. Sharma, A. and Straubinger, R.M. (1994) "Novel taxol formulations: preparation and characterization of taxol-containing liposomes", Pharm. Res. 11, 889-896.
17. Torchilin, V.P., Levchenko, T.S., Lukyanov, A.N., Khaw, B.A., Klibanov, A.L., Rammohan, R., Samokhin, G.P. and Whiteman, K.R. (2001a) "p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups", Biochim. Biophys. Acta 1511, 397-411.
18. Torchilin, V.P., Rammohan, R., Weissig, V. and Levchenko, T.S. (2001b) "TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors", Proc. Natl Acad. Sci. USA 98, 8786-8791.
19. Torchilin, V.P., Lukyanov, A.N., Gao, Z. and Mazzola, L. (2002) "Polymer-lipid micelles as non-targeted and targeted pharmaceutical carriers", Polym. Prep. 43, 677-678.
20. Trubetskoy, V.S. and Torchilin, V.P. (1995) "Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents", Adv. Drug Deliv. Rev. 16, 311-320.
21. Weissig, V., Whiteman, K.R. and Torchilin, V.P. (1998) "Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice", Pharm. Res. 15, 1552-1556.
22. Wenk, M.R., Fahr, A., Reszka, R. and Seelig, J. (1996) "Paclitaxel partitioning into lipid bilayers", J. Pharm. Sci. 85, 228-231.
23. Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D.A., Torchilin, V.P. and Jain, R.K. (1995) "Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size", Cancer Res. 55, 3752-3756.